Find your path to Jigar
1,267 people in our graph can introduce you to Jigar.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Lisa Purcell to introduce you to Jigar
You →Lisa · together at Third Rock Ventures (2024–2026) →Jigar
Ask Jamie Chen to introduce you to Jigar
You →Jamie · 11 people · together at Third Rock Ventures →Jigar
Sign up to find every way you can get introduced to Jigar
- Your email: the people you already email who know Jigar
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Jigar
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Partner at Third Rock Ventures who joined in 2022, previously president and CEO of Constellation Pharmaceuticals until its 2021 acquisition and chief business officer at Jounce Therapeutics through its IPO. He holds an MBA from Columbia and a biochemistry/economics degree from Rutgers, and serves on boards at Flare Therapeutics, Synnovation, and TRIANA Biomedicines.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Experience
- Third Rock VenturesPartnercurrent2022 — present
- Third Rock VenturesBoard Member - Mass Medicines, Inc.current2025 — present
- Third Rock VenturesBoard Member - Synnovation, Inc.current2024 — present
- Third Rock VenturesBoard Member - Flare Therapeutics, Inc.current2022 — present
- TRIANA BiomedicinesChair of the Board of Directorscurrent2022 — presentGreater Boston
- Jounce Therapeutics, Inc.Chair of the Board of Directors2021 — 2023Greater Boston
- Constellation Pharmaceuticals, Inc. (Acquired)Chief Executive Officer2017 — 2021Cambridge, Massachusetts
- Jounce Therapeutics, Inc.Chief Business Officer2012 — 2017Greater Boston Area
- Constellation PharmaceuticalsHead of Corporate Development2009 — 2013Greater Boston Area
- Red Abbey Venture PartnersKauffman Fellow (2005-2007), Principal (2007-2009) Venture Partner (2009)2005 — 2009Baltimore, Maryland Area
- PfizerSummer - New Product Development - Marketing2004Greater New York City Area
- BiogenMarket & Business Development1999 — 2003Cambridge, Massachuesetts
- A.T. KearneyBusiness Analyst1998 — 1999Greater New York City Area
Skills & more
+2 more
Drug DevelopmentOncologyFrom Jigar's professional profile.
Investments
Board seats
Flare Therapeutics, Inc.Synnovation, Inc.Triana Bio
Per the firm's website.
Colleagues at Third Rock Ventures
Network1
Investors connected to Jigar in public investor directories — a warm-intro map.
Frequently asked questions
- Who is Jigar Raythatha?
- Partner at Third Rock Ventures who joined in 2022, previously president and CEO of Constellation Pharmaceuticals until its 2021 acquisition and chief business officer at Jounce Therapeutics through its IPO. He holds an MBA from Columbia and a biochemistry/economics degree from Rutgers, and serves on boards at Flare Therapeutics, Synnovation, and TRIANA Biomedicines.
- Where does Jigar Raythatha work?
- Jigar Raythatha is Partner at Third Rock Ventures.
- What does Jigar Raythatha invest in?
- Jigar Raythatha invests in Biotech, Digital Health, Healthtech, Medical Devices.
- What boards does Jigar Raythatha sit on?
- Jigar Raythatha holds tracked board seats at Flare Therapeutics, Inc., Synnovation, Inc., Triana Bio.
- Where did Jigar Raythatha go to school?
- Jigar Raythatha studied at Columbia Business School (MBA); Rutgers University (B.A., Biochemistry/Economics).
Same school
Also attended Columbia Business School1,170
+ 1,164 more
Also attended Rutgers University312
+ 306 more
Shared employers
Also worked at TRIANA Biomedicines4
Also worked at Jounce Therapeutics, Inc.8
+ 2 more
Also worked at Constellation Pharmaceuticals8
+ 2 more
Also worked at Pfizer400
+ 394 more
















































